Ezra AI provides early cancer detection by combining advanced medical imaging technology and AI technology.
Ezra has created a new way to screen for cancer using full-body MRI technology assisted by Artificial Intelligence. The company's first AI, developed to assist radiologists when interpreting MRI images of the prostate, is an FDA-cleared software as a medical device.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 23, 2019 | Series A | $18M | 1 | — | — | Detail |
Nov 15, 2018 | Seed | $4M | 1 | — | — | Detail |